CereProc Ltd was founded in 2006 with the aim of producing characterful speech synthesis. The CereVoice system is available on many platforms, both as s erver and on device. CereProc’s innovation has been ahead of the industry creating the first commercial voices with emotion change and leading the way in voice cloning. CereProc was acquired by Capacity in 2024 where we are actively working on creating customer service management using modern AI technology and fluid communicative speech synthesis.
Dr Aylett was one of the original founders of CereProc. He was CTO from 2066-2013 when he became CSO (Chief Science Officer) to focus on innovation within speech synthesis. CereProc launched the first commercial emotional voices in 2006, the first voice cloning system on 2010 and the first on-device neural TTS system CereWave in 2020. See some of our past projects here. Over the years we worked with companies such as Intel, Hanson Robotics, Honda Research Institute and the Scott Morgan Foundation.